Gigabases

Gigabases is a private Swiss synthetic biology company and ETH Zurich spin-off focused on AI-enabled protein and DNA design. The company offers a web-based platform that lets researchers search large protein structure libraries, design custom proteins in 3D, and convert those designs into ready-to-order, sequence-verified expression plasmids. Its positioning is primarily as a research tools and digital biology platform rather than a therapeutics developer with a disclosed clinical pipeline. Gigabases also describes broader genome-design capabilities for synthetic DNA, pathways, and engineered organisms for biotechnology and biopharmaceutical applications. Overall, the company appears to serve researchers and partners seeking computational protein design, plasmid delivery, and synthetic biology enablement.